This article aims to review recent evidence, mostly from randomized controlled trials, on new drug and nondrug based therapies for the prevention and treatment of COPD exacerbations. Research in this area—both industry driven and academic—has increased greatly over the past decade, and new studies and drugs are rapidly emerging.